Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pferdewetten.de AG | EMH | Nov 15, 2024 | 3.92 | +3.70 |
PFERDEWETTEN.DE NA NEUE | EMH0 | Nov 15, 2024 | 2.50 | 0.00 |
PFIZER INC.CDR REG.S | PFEB | Nov 15, 2024 | 7.90 | -3.07 |
Pfizer, Inc. | PFE | Nov 15, 2024 | 23.59 | -5.73 |
PGE Polska Grupa Energetyczna SA | 6PG | Nov 15, 2024 | 1.58 | +6.82 |
Pharmamar S.A. | PMRA | Nov 15, 2024 | 74.95 | -4.70 |
Pharmanutra S.p.A. | 761 | Nov 15, 2024 | 55.40 | -1.42 |
Pharmaron Beijing Co Ltd | 17Q1 | Nov 15, 2024 | 1.69 | -1.74 |
PHARMASGP HOLDING SE O.N. | PSG | Nov 15, 2024 | 25.40 | +4.10 |
Pharmaust Ltd. | ECQ | Nov 15, 2024 | 0.13 | 0.00 |
Pharming Group N.V. - ADS, each representing 10 ordinary sha | PHG | Nov 15, 2024 | 7.05 | -0.70 |
Pharming Group NV | PHGN | Nov 15, 2024 | 0.72 | +2.11 |
PHarol SGPS SA | PTCA | Nov 15, 2024 | 0.04 | +3.52 |
Pharos Energy Plc | OCS1 | Nov 15, 2024 | 0.26 | +2.36 |
Pharvaris N.V. - Ordinary Shares | 9EN | Nov 15, 2024 | 18.70 | +0.54 |
PHASE HOLO.IMAG.PHI SK-20 | L5W | Nov 15, 2024 | 0.15 | -1.96 |
PHAXIAM THERAPEUT. EO 1,- | 2E40 | Nov 15, 2024 | 1.54 | -1.91 |
PHC Holdings Corporation | 2GY | Nov 15, 2024 | 6.25 | +0.81 |
PhenixFIN | Q29 | Nov 15, 2024 | 42.60 | -2.29 |
Phenom Resources Corp | 1PY0 | Nov 15, 2024 | 0.27 | +3.88 |
Phibro Animal Health Corporation - Class A | PB8 | Nov 15, 2024 | 23.40 | -0.85 |
Phicomm AG | HBD1 | Nov 15, 2024 | 1.00 | +2.56 |
Philion Se Bearer NPV | PH6 | Nov 15, 2024 | 0.43 | +0.46 |
Philip Morris Cr A.S. | TBK | Nov 15, 2024 | 634.00 | 0.00 |
Philip Morris International Inc | 4I1 | Nov 15, 2024 | 121.68 | +0.93 |
Philips KON | PHI1 | Nov 15, 2024 | 24.60 | +0.24 |
Phillips 66 | R66 | Nov 15, 2024 | 124.34 | +0.76 |
Phillips Edison & Company Inc | 9R4 | Nov 15, 2024 | 36.20 | -1.63 |
Philly Shipyard | 65I | Nov 15, 2024 | 5.68 | -1.39 |
Philogen S.p.a. | 78Q | Nov 15, 2024 | 18.85 | -0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.